AU6523200A - Vitronectin receptor antagonists useful for the treatment of strokes - Google Patents

Vitronectin receptor antagonists useful for the treatment of strokes

Info

Publication number
AU6523200A
AU6523200A AU65232/00A AU6523200A AU6523200A AU 6523200 A AU6523200 A AU 6523200A AU 65232/00 A AU65232/00 A AU 65232/00A AU 6523200 A AU6523200 A AU 6523200A AU 6523200 A AU6523200 A AU 6523200A
Authority
AU
Australia
Prior art keywords
strokes
treatment
receptor antagonists
vitronectin receptor
antagonists useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65232/00A
Inventor
Frank C Barone
Tian-Li Yue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU6523200A publication Critical patent/AU6523200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU65232/00A 1999-08-06 2000-08-04 Vitronectin receptor antagonists useful for the treatment of strokes Abandoned AU6523200A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14756799P 1999-08-06 1999-08-06
US60147567 1999-08-06
PCT/US2000/021433 WO2001010867A1 (en) 1999-08-06 2000-08-04 Vitronectin receptor antagonists useful for the treatment of strokes

Publications (1)

Publication Number Publication Date
AU6523200A true AU6523200A (en) 2001-03-05

Family

ID=22522092

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65232/00A Abandoned AU6523200A (en) 1999-08-06 2000-08-04 Vitronectin receptor antagonists useful for the treatment of strokes

Country Status (4)

Country Link
EP (1) EP1208101A4 (en)
JP (1) JP2003506452A (en)
AU (1) AU6523200A (en)
WO (1) WO2001010867A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2001114518A (en) 1999-09-29 2003-04-20 Орто-Макнейл Фармасьютикал, Инк. (Us) ISONIPECOTAMIDES FOR TREATMENT OF INTEGRIN-MEDIATED DISORDERS
US7081460B2 (en) 2001-04-09 2006-07-25 Ortho-Mcneil Pharmaceutical, Inc. Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
WO2003059251A2 (en) 2001-10-22 2003-07-24 The Scripps Research Institute Antibody targeting compounds
US8518927B2 (en) 2009-02-10 2013-08-27 The Scripps Research Institute Chemically programmed vaccination

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10504825A (en) * 1994-08-22 1998-05-12 スミスクライン・ビーチャム・コーポレイション Bicyclic compound
SI0910563T1 (en) * 1995-06-29 2003-10-31 Smithkline Beecham Corporation Integrin receptor antagonists
CA2241633A1 (en) * 1995-12-29 1997-07-10 William Henry Miller Vitronectin receptor antagonists
UA60311C2 (en) * 1996-10-02 2003-10-15 Смітклайн Бічам Корпорейшн Vitronectin receptor antagonists
AU8689798A (en) * 1997-08-04 1999-02-22 Smithkline Beecham Corporation Integrin receptor antagonists
EP1027337A4 (en) * 1997-09-04 2002-04-03 Smithkline Beecham Corp Integrin receptor antagonists

Also Published As

Publication number Publication date
EP1208101A1 (en) 2002-05-29
JP2003506452A (en) 2003-02-18
WO2001010867A1 (en) 2001-02-15
EP1208101A4 (en) 2003-03-19

Similar Documents

Publication Publication Date Title
EP1425277B8 (en) Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
IL147977A0 (en) Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain
PL356990A1 (en) Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists
HUP0202253A3 (en) Selective iglur5 receptor antagonists for the treatment of migraine
SI1379647T1 (en) Antagonist antibodies of a mammalian cytokine or its receptor for the treatment of allergy
AU2003267088A1 (en) Chemokine receptor antagonists as therapeutic agents
AU6990000A (en) Novel integrin receptor antagonists
IL145166A0 (en) Biphenyl derivatives as antagonists of the neurokinine-1 receptor
HUP0200830A3 (en) Process for the preparation of substituted pyrimidines
GC0000203A (en) Vitronectin receptor antagonists
AU6523200A (en) Vitronectin receptor antagonists useful for the treatment of strokes
AU2003264297A1 (en) Use of vanilloid receptor antagonists for the treatment of pain
WO2000007544A3 (en) Vitronectin receptor antagonists
AU6051200A (en) Il-8 receptor antagonists
AU2002315522A1 (en) Receptor agonists useful for the treatment of pain
AU5168900A (en) Il-8 receptor antagonists
AU5748300A (en) Il-8 receptor antagonists
PL352222A1 (en) Antagonists of the il-8 receptor
AU2003245995A1 (en) Use of gaba-c receptor antagonists for the treatment of myopia
AU2512800A (en) Alpha1-adrenergic receptor antagonists
AU5622400A (en) Il-8 receptor antagonists
SI1200402T1 (en) Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain
TW378649U (en) Structure of the bottle
TW382965U (en) Structure of scalding-proof handle for the wash-free cups
AU7003400A (en) New use for alpha receptor stimulating compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase